Baquiran D C, Dantis L, McKerrow J
Memorial Hospital for Cancer and Allied Diseases, New York 10022, USA.
Semin Oncol Nurs. 1996 May;12(2):130-41. doi: 10.1016/s0749-2081(96)80007-6.
To provide a review of the use of monoclonal antibodies (MAbs) for diagnosis and therapy, the obstacles affecting their usefulness, and nursing considerations unique to MAb-based treatments.
Research studies, review articles, and book chapters pertaining to MAbs in cancer diagnosis and therapy.
Recent clinical trials have shown the potential of MAbs as diagnostic and therapeutic tools in cancer. MAbs may be used alone or conjugated with drugs, radionuclides, and toxins; however numerous obstacles limit their effectiveness.
Oncology nurses caring for patients receiving MAb-based therapies play an important role in the implementation of the patient's regimen. Hypersensitivity reactions, constitutional symptoms, and serum sickness are toxic effects that require monitoring and patient education.
综述单克隆抗体(MAb)在诊断和治疗中的应用、影响其效用的障碍以及基于单克隆抗体治疗的独特护理考量。
关于单克隆抗体在癌症诊断和治疗方面的研究、综述文章及书籍章节。
近期临床试验已显示单克隆抗体作为癌症诊断和治疗工具的潜力。单克隆抗体可单独使用或与药物、放射性核素及毒素结合使用;然而,众多障碍限制了其有效性。
护理接受基于单克隆抗体治疗的肿瘤患者的肿瘤专科护士在实施患者治疗方案中发挥着重要作用。过敏反应、全身症状和血清病是需要监测及对患者进行教育的毒性反应。